DRI Ecstasy Plus Assay— 510(k) K240670

Substantially Equivalent

Microgenics Corporation

FDA 510(k) clearance K240670 for DRI Ecstasy Plus Assay, Substantially Equivalent on 2024-10-30. Applicant: Microgenics Corporation. Device class: 2.

Clearance details

Applicant
Microgenics Corporation
Product code
Code DKZ
Device class
Class 2
Regulation
21 CFR 862.3100
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Fremont, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DKZ

view all

More clearances from Microgenics Corporation

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.